239 related articles for article (PubMed ID: 7958853)
1. Regulation of mdm2 expression by p53: alternative promoters produce transcripts with nonidentical translation potential.
Barak Y; Gottlieb E; Juven-Gershon T; Oren M
Genes Dev; 1994 Aug; 8(15):1739-49. PubMed ID: 7958853
[TBL] [Abstract][Full Text] [Related]
2. Wild type p53 can mediate sequence-specific transactivation of an internal promoter within the mdm2 gene.
Juven T; Barak Y; Zauberman A; George DL; Oren M
Oncogene; 1993 Dec; 8(12):3411-6. PubMed ID: 8247544
[TBL] [Abstract][Full Text] [Related]
3. Human MDM2 isoforms translated differentially on constitutive versus p53-regulated transcripts have distinct functions in the p53/MDM2 and TSG101/MDM2 feedback control loops.
Cheng TH; Cohen SN
Mol Cell Biol; 2007 Jan; 27(1):111-9. PubMed ID: 17060450
[TBL] [Abstract][Full Text] [Related]
4. Alternative and aberrant messenger RNA splicing of the mdm2 oncogene in invasive breast cancer.
Lukas J; Gao DQ; Keshmeshian M; Wen WH; Tsao-Wei D; Rosenberg S; Press MF
Cancer Res; 2001 Apr; 61(7):3212-9. PubMed ID: 11306511
[TBL] [Abstract][Full Text] [Related]
5. A novel exon within the mdm2 gene modulates translation initiation in vitro and disrupts the p53-binding domain of mdm2 protein.
Veldhoen N; Metcalfe S; Milner J
Oncogene; 1999 Nov; 18(50):7026-33. PubMed ID: 10597303
[TBL] [Abstract][Full Text] [Related]
6. p53-independent activation of the hdm2-P2 promoter through multiple transcription factor response elements results in elevated hdm2 expression in estrogen receptor alpha-positive breast cancer cells.
Phelps M; Darley M; Primrose JN; Blaydes JP
Cancer Res; 2003 May; 63(10):2616-23. PubMed ID: 12750288
[TBL] [Abstract][Full Text] [Related]
7. Translational enhancement of mdm2 oncogene expression in human tumor cells containing a stabilized wild-type p53 protein.
Landers JE; Cassel SL; George DL
Cancer Res; 1997 Aug; 57(16):3562-8. PubMed ID: 9270029
[TBL] [Abstract][Full Text] [Related]
8. A functional p53-responsive intronic promoter is contained within the human mdm2 gene.
Zauberman A; Flusberg D; Haupt Y; Barak Y; Oren M
Nucleic Acids Res; 1995 Jul; 23(14):2584-92. PubMed ID: 7651818
[TBL] [Abstract][Full Text] [Related]
9. Induction of MDM2-P2 transcripts correlates with stabilized wild-type p53 in betel- and tobacco-related human oral cancer.
Ralhan R; Sandhya A; Meera M; Bohdan W; Nootan SK
Am J Pathol; 2000 Aug; 157(2):587-96. PubMed ID: 10934161
[TBL] [Abstract][Full Text] [Related]
10. mdm2-P2 transcript levels predict the functional activity of the p53 tumor suppressor in primary leukemic cells.
Bull EK; Chakrabarty S; Brodsky I; Haines DS
Oncogene; 1998 Apr; 16(17):2249-57. PubMed ID: 9619834
[TBL] [Abstract][Full Text] [Related]
11. Regulation of transcriptional activation of mdm2 gene by p53 in response to UV radiation.
Saucedo LJ; Carstens BP; Seavey SE; Albee LD; Perry ME
Cell Growth Differ; 1998 Feb; 9(2):119-30. PubMed ID: 9486848
[TBL] [Abstract][Full Text] [Related]
12. Constitutive and DNA damage inducible activation of pig3 and MDM2 genes by tumor-derived p53 mutant C277Y.
Pospísilová S; Siligan C; Ban J; Jug G; Kovar H
Mol Cancer Res; 2004 May; 2(5):296-304. PubMed ID: 15192123
[TBL] [Abstract][Full Text] [Related]
13. Characterisation of a novel p53 down-regulated promoter in intron 3 of the human MDM2 oncogene.
Liang H; Lunec J
Gene; 2005 Nov; 361():112-8. PubMed ID: 16202543
[TBL] [Abstract][Full Text] [Related]
14. p53 binds to a constitutively nucleosome free region of the mdm2 gene.
Xiao G; White D; Bargonetti J
Oncogene; 1998 Mar; 16(9):1171-81. PubMed ID: 9528859
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of multiple MDM2 messenger RNAs and proteins in normal and tumorigenic breast epithelial cells.
Gudas JM; Nguyen H; Klein RC; Katayose D; Seth P; Cowan KH
Clin Cancer Res; 1995 Jan; 1(1):71-80. PubMed ID: 9815889
[TBL] [Abstract][Full Text] [Related]
16. p53 Stability and activity is regulated by Mdm2-mediated induction of alternative p53 translation products.
Yin Y; Stephen CW; Luciani MG; Fåhraeus R
Nat Cell Biol; 2002 Jun; 4(6):462-7. PubMed ID: 12032546
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the 5' and 3' untranslated regions in murine mdm2 mRNAs.
Mendrysa SM; McElwee MK; Perry ME
Gene; 2001 Feb; 264(1):139-46. PubMed ID: 11245988
[TBL] [Abstract][Full Text] [Related]
18. ETS1 and ETS2 in p53 regulation: spatial separation of ETS binding sites (EBS) modulate protein: DNA interaction.
Venanzoni MC; Robinson LR; Hodge DR; Kola I; Seth A
Oncogene; 1996 Mar; 12(6):1199-1204. PubMed ID: 8649821
[TBL] [Abstract][Full Text] [Related]
19. Expression of MDM2 during mammary tumorigenesis.
Pinkas J; Naber SP; Butel JS; Medina D; Jerry DJ
Int J Cancer; 1999 Apr; 81(2):292-8. PubMed ID: 10188733
[TBL] [Abstract][Full Text] [Related]
20. The high levels of p53 present in adenovirus early region 1-transformed human cells do not cause up-regulation of MDM2 expression.
Grand RJ; Lecane PS; Owen D; Grant ML; Roberts S; Levine AJ; Gallimore PH
Virology; 1995 Jul; 210(2):323-34. PubMed ID: 7618270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
